-
The St. Louis Board of Aldermen said no to a bill to extend a blight determination on the Cortex Innovation District, marking an end to nearly two decades in the area.
-
An aldermanic committee moved forward with a plan to renew a blight determination for St. Louis’ Cortex district in an effort to finish redeveloping the area.
-
The connector's first phase will rework 1.4 miles of road between Vandeventer Avenue and Tower Grove Park, repaving Tower Grove Avenue and installing new protected bike lanes and pedestrian paths.
-
FDA officials say the lab in the Central West End will stay open after the Department of Government Efficiency said it was terminating the facility’s lease.
-
The company is developing diagnostic devices that can detect airborne pathogens in just minutes.
-
The region is vying for a $160 million NSF grant to leverage existing neuroscience research prowess into new products and technology.
-
Washington University School of Medicine’s $616 million research facility will bring together experts in a wide variety of neurological conditions who are working toward new treatments and technologies.
-
Early-stage companies are always a risky proposition, but these days they have to find new ways to deliver products and services and reach investors online.
-
The Cortex Innovation Community has named its next president and CEO.Sam Fiorello will begin the job March 30, replacing Dennis Lower, who announced last…
-
In nearly two decades, the Cortex Innovation Community transformed a once-blighted, industrial part of St. Louis’ Central West End neighborhood into a…